None listed
Conditions
Interventions
None listed
Sponsors
Kyung Hee University Oriental Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Male or female patients aged 19 years or older 2) Patients diagnosed with stroke (including ischemic stroke, hemorrhagic stroke, and subarachnoid hemorrhage; ICD-10 codes I60, I61, I63) based on clinical presentation and neuroimaging findings, who are prescribed and taking ChungHyulDan (HH333), an in-house herbal formulation of Kyung Hee University Korean Medicine Hospital, for the purpose of secondary stroke prevention in either the outpatient clinic or inpatient ward 3) Patients (or their legal guardians/proxies) who fully understand the purpose and nature of the study and voluntarily agree to participate by providing written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with traumatic hemorrhagic stroke or traumatic subarachnoid hemorrhage 2) Patients who, based on clinical judgment and examination or laboratory findings, are deemed by the investigator to be physically or psychologically unsuitable for participation in the registry study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stroke recurrence (time of recurrence, stroke site, stroke type, cerebral infarction TOAST classification, stroke surgery history, etc.) | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic information;Stroke history;Stroke symptom;Laboratory test;ChungHyulDan prescription details (prescription date, number of prescription days);Stroke assessment (Paralysis of the upper and lower limbs, activities of daily living);Concomitant treatment (Western medication) | — |
Countries
Korea, Republic of
Contacts
Public ContactHan-Gyul Lee
KyungHee University Medical Center
Outcome results
None listed